Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial-Reference-Cited by-同舟云学术

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Published:2016-11 Issue:10059 Volume:388 Page:2479-2491
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Serruys Patrick W,Chevalier Bernard,Sotomi Yohei,Cequier Angel,Carrié Didier,Piek Jan J,Van Boven Ad J,Dominici Marcello,Dudek Dariusz,McClean Dougal,Helqvist Steffen,Haude Michael,Reith Sebastian,de Sousa Almeida Manuel,Campo Gianluca,Iñiguez Andrés,Sabaté Manel,Windecker Stephan,Onuma Yoshinobu

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Biodegradable stents: they do their job and disappear;Waksman;J Invasive Cardiol,2006

2. ABSORB II randomized controlled trial

3. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

4. Coronary vasodilatory action of elgodipine in coronary artery disease;Suryapranata;Am J Cardiol,1992

5. Coronary vasodilatory action after a single dose of nicorandil;Suryapranata;Am J Cardiol,1988

Cited by 483 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial;Frontiers in Cardiovascular Medicine;2024-09-10

2. Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model;Bioactive Materials;2024-09

3. Polydiolcitrate–MoS₂ Composite for 3D Printing Radio-Opaque, Bioresorbable Vascular Scaffolds;ACS Applied Materials & Interfaces;2024-08-05

4. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis;JACC: Cardiovascular Interventions;2024-08

5. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30